110 related articles for article (PubMed ID: 16317558)
1. Cell cycle effects of vinflunine, the most recent promising Vinca alkaloid, and its interaction with radiation, in vitro.
Simoens C; Vermorken JB; Korst AE; Pauwels B; De Pooter CM; Pattyn GG; Lambrechts HA; Breillout F; Lardon F
Cancer Chemother Pharmacol; 2006 Aug; 58(2):210-8. PubMed ID: 16317558
[TBL] [Abstract][Full Text] [Related]
2. Further mechanistic unravelling of the influence of the cell cycle effects on the radiosensitising mechanism of vinflunine, in vitro.
Simoens C; Pauwels B; Vermorken JB; Pattyn GG; Lambrechts HA; Breillout F; Lardon F
Cancer Chemother Pharmacol; 2008 Jul; 62(2):183-93. PubMed ID: 17899084
[TBL] [Abstract][Full Text] [Related]
3. The radiosensitising effect of difluorodeoxyuridine, a metabolite of gemcitabine, in vitro.
Pauwels B; Korst AE; Lambrechts HA; Pattyn GG; de Pooter CM; Lardon F; Vermorken JB
Cancer Chemother Pharmacol; 2006 Aug; 58(2):219-28. PubMed ID: 16331496
[TBL] [Abstract][Full Text] [Related]
4. Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules.
Ngan VK; Bellman K; Panda D; Hill BT; Jordan MA; Wilson L
Cancer Res; 2000 Sep; 60(18):5045-51. PubMed ID: 11016627
[TBL] [Abstract][Full Text] [Related]
5. Head and neck carcinoma cell lines are sensitive to vinflunine in vitro.
Erjala K; Raitanen M; Kulmala J; Grénman R
Anticancer Res; 2005; 25(6B):4363-7. PubMed ID: 16309241
[TBL] [Abstract][Full Text] [Related]
6. Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.
Etievant C; Barret JM; Kruczynski A; Perrin D; Hill BT
Invest New Drugs; 1998; 16(1):3-17. PubMed ID: 9740539
[TBL] [Abstract][Full Text] [Related]
7. Combination of gamma-radiation antagonizes the cytotoxic effects of vincristine and vinblastine on both mitotic arrest and apoptosis.
Sui M; Fan W
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1151-8. PubMed ID: 15752896
[TBL] [Abstract][Full Text] [Related]
8. Exploring the mechanisms of action of the novel microtubule inhibitor vinflunine.
Jordan MA; Horwitz SB; Lobert S; Correia JJ
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S6-S12. PubMed ID: 18538179
[TBL] [Abstract][Full Text] [Related]
9. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.
Jean-Decoster C; Brichese L; Barret JM; Tollon Y; Kruczynski A; Hill BT; Wright M
Anticancer Drugs; 1999 Jul; 10(6):537-43. PubMed ID: 10885901
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of the radiosensitizing and cell cycle effects of vinflunine and vinorelbine, in vitro.
Simoens C; Lardon F; Pauwels B; De Pooter CM; Lambrechts HA; Pattyn GG; Breillout F; Vermorken JB
BMC Cancer; 2008 Feb; 8():65. PubMed ID: 18312675
[TBL] [Abstract][Full Text] [Related]
11. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.
Kruczynski A; Barret JM; Etiévant C; Colpaert F; Fahy J; Hill BT
Biochem Pharmacol; 1998 Mar; 55(5):635-48. PubMed ID: 9515574
[TBL] [Abstract][Full Text] [Related]
12. Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity.
Gan PP; Kavallaris M
Cancer Res; 2008 Dec; 68(23):9817-24. PubMed ID: 19047161
[TBL] [Abstract][Full Text] [Related]
13. Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP.
Makarov AA; Tsvetkov PO; Villard C; Esquieu D; Pourroy B; Fahy J; Braguer D; Peyrot V; Lafitte D
Biochemistry; 2007 Dec; 46(51):14899-906. PubMed ID: 18052208
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
Schwock J; Pham NA; Cao MP; Hedley DW
Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, metabolites, and preclinical safety of vinflunine.
Lobert S; Puozzo C
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S28-33. PubMed ID: 18538176
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development.
Kruczynski A; Poli M; Dossi R; Chazottes E; Berrichon G; Ricome C; Giavazzi R; Hill BT; Taraboletti G
Eur J Cancer; 2006 Nov; 42(16):2821-32. PubMed ID: 16973349
[TBL] [Abstract][Full Text] [Related]
17. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
[TBL] [Abstract][Full Text] [Related]
18. Differential gene expression profiles in paclitaxel-induced cell cycle arrest and apoptosis in human breast cancer MCF-7 cells.
Wang J; He FT; Tzang CH; Fong WF; Xiao PG; Han R; Yang MS
Yao Xue Xue Bao; 2005 Dec; 40(12):1099-104. PubMed ID: 16496673
[TBL] [Abstract][Full Text] [Related]
19. [Antitumor effects of novel triterpene from Celastrus hypoleucus on human colorectal cancer cell line RKO in vitro].
Mao JS; Wang KW; Zheng S; Pan YJ
Zhongguo Zhong Yao Za Zhi; 2006 Sep; 31(17):1450-3. PubMed ID: 17087089
[TBL] [Abstract][Full Text] [Related]
20. Markedly diminished drug resistance-inducing properties of vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine) relative to vinorelbine, identified in murine and human tumour cells in vivo and in vitro.
Etiévant C; Kruczynski A; Barret JM; Tait AS; Kavallaris M; Hill BT
Cancer Chemother Pharmacol; 2001 Jul; 48(1):62-70. PubMed ID: 11488526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
